Assembly, purification and crystallization of an active HIV-1 reverse transcriptase initiation complex

Nucleic Acids Research

Volumn 30, Issue 22, 2002, Pages 4855-4863

  Pata, Janice D ^a   King, Bradford R ^a   Steitz, Thomas A ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; DEOXYRIBONUCLEOTIDE; PRIMER RNA; RIBOZYME; RNA DIRECTED DNA POLYMERASE; TRANSFER RNA;

COMPLEX FORMATION; CONTROLLED STUDY; CRYSTALLIZATION; DNA SYNTHESIS; ENZYME PURIFICATION; GEL FILTRATION CHROMATOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REVIEW; RNA STRUCTURE; RNA TRANSCRIPTION; SEQUENCE HOMOLOGY; TITRIMETRY; TRANSCRIPTION INITIATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0037112729     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkf620     Document Type: Review

References (40)

1. Arts, E.J. and Le Grice, S.F. (1998) Interaction of retroviral reverse transcriptase with template-primer duplexes during replication. Prog. Nucleic Acid Res. Mol. Biol., 58, 339-393.
2. Arts, E.J. and Wainberg, M.A. (1996) Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription. Adv. Virus Res., 46, 97-163.
3. Zhang, H., Dornadula, G., Wu, Y., Havlir, D., Richman, D.D. and Pomerantz, R.J. (1996) Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivo. J. Virol., 70, 628-634.
4. Lys3 in the fidelity and efficacy of plus strand DNA transfer during HIV-1 reverse transcription. J. Biol. Chem., 274, 4412-4420.
5. Oude Essink, B.B., Das, A.T. and Berkhout, B. (1996) HIV-1 reverse transcriptase discriminates against non-self tRNA primers. J. Mol. Biol., 264, 243-254.
6. Lanchy, J.M., Keith, G., Le Grice, S.F., Ehresmann, B., Ehresmann, C. and Marquet, R. (1998) Contacts between reverse transcriptase and the primer strand govern the transition from initiation to elongation of HIV-1 reverse transcription. J. Biol. Chem., 273, 24425-24432.
7. Lys3. EMBO J., 15, 917-924.
8. Lanchy, J.M., Ehresmann, C., Le Grice, S.F., Ehresmann, B. and Marquet, R. (1996) Binding and kinetic properties of HIV-1 reverse transcriptase markedly differ during initiation and elongation of reverse transcription. EMBO J., 15, 7178-7187.
9. Vaccaro, J.A., Singh, H.A. and Anderson, K.S. (1999) Initiation of minus-strand DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. Biochemistry, 38, 15978-15985.
10. Thrall, S.H., Krebs, R., Wohrl, B.M., Cellai, L., Goody, R.S. and Restle, T. (1998) Pre-steady-state kinetic characterization of RNA-primed initiation of transcription by HIV-1 reverse transcriptase and analysis of the transition to a processive DNA-primed polymerization mode. Biochemistry, 37, 13349-13358.
11. Lys3 interactions inhibiting primer utilization by retroviral reverse transcriptases. Proc. Natl Acad. Sci. USA, 93, 10063-10068.
12. Rigourd, M., Lanchy, J.M., Le Grice, S.F., Ehresmann, B., Ehresmann, C. and Marquet, R. (2000) Inhibition of the initiation of HIV-1 reverse transcription by 3′-azido-3′-deoxythymidine. Comparison with elongation. J. Biol. Chem., 275, 26944-26951.
13. Vaccaro, J.A. and Anderson, K.S. (1998) Implication of the tRNA initiation step for human immunodeficiency virus type 1 reverse transcriptase in the mechanism of 3′-azido-3′-deoxythymidine (AZT) resistance. Biochemistry, 37, 14189-14194.
14. Kohlstaedt, L.A., Wang, J., Friedman, J.M., Rice, P.A. and Steitz, T.A. (1992) Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science, 256, 1783-1790.
15. Huang, H., Chopra, R., Verdine, G.L. and Harrison, S.C. (1998) Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science, 282, 1669-1675.
16. Ding, J., Das, K., Hsiou, Y., Sarafianos, S.G., Clark, A.D., Jr, Jacobo-Molina, A., Tantillo, C., Hughes, S.H. and Arnold, E. (1998) Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 Å resolution. J. Mol. Biol., 284, 1095-1111.
17. Jacobo-Molina, A., Ding, J., Nanni, R.G., Clark, A.D., Jr, Lu, X., Tantillo, C., Williams, R.L., Kamer, G., Ferris, A.L., Clark, P. et al. (1993) Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc. Natl Acad. Sci. USA, 90, 6320-6324.
18. Sarafianos, S.G., Das, K., Tantillo, C., Clark, A.D., Jr, Ding, J., Whitcomb, J.M., Boyer, P.L., Hughes, S.H. and Arnold, E. (2001) Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J., 20, 1449-1461.
19. Jäger, J., Restle, T. and Steitz, T.A. (1998) The structure of HIV-1 reverse transcriptase complexed with an RNA pseudoknot inhibitor. EMBO J., 17, 4535-4542.
20. Lys3 to reverse transcriptase from human immunodeficiency virus type I. EMBO J., 14, 2679-2687.
21. Price, S.R., Ito, N., Oubridge, C., Avis, J.M. and Nagai, K. (1995) Crystallization of RNA-protein complexes. I. Methods for the large-scale preparation of RNA suitable for crystallographic studies. J. Mol. Biol., 249, 398-408.
22. Lee, S.Y. and Rasheed, S. (1990) A simple procedure for maximum yield of high-quality plasmid DNA. Biotechniques, 9, 676-679.
23. Jeruzalmi, D. and Steitz, T.A. (1998) Structure of T7 RNA polymerase complexed to the transcriptional inhibitor T7 lysozyme. EMBO J., 17, 4101-4113.
24. Shields, T.P., Mollova, E., Ste Marie, L., Hansen, M.R. and Pardi, A. (1999) High-performance liquid chromatography purification of homogenous-length RNA produced by trans cleavage with a hammerhead ribozyme. RNA, 5, 1259-1267.
25. Forster, A.C., Davies, C., Hutchins, C.J. and Symons, R.H. (1990) Characterization of self-cleavage of viroid and virusoid RNAs. Methods Enzymol., 181, 583-607.
26. Milligan, J.F., Groebe, D.R., Witherell, G.W. and Uhlenbeck, O.C. (1987) Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res., 15, 8783-8798.
27. Le Grice, S.F. and Gruninger-Leitch, F. (1990) Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography. Eur. J. Biochem., 187, 307-314.
28. Boyer, P.L., Ding, J., Arnold, E. and Hughes, S.H. (1994) Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase. Antimicrob. Agents Chemother., 38, 1909-1914.
29. Le Grice, S.F., Cameron, C.E. and Benkovic, S.J. (1995) Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase. Methods Enzymol., 262, 130-144.
30. Gln2 as a primer in an in vitro primer-utilization assay. Proc. Natl Acad. Sci. USA, 89, 9652-9656.
31. Ferre-d'Amare, A.R. and Doudna, J.A. (1997) Establishing suitability of RNA preparations for crystallization. Determination of polydispersity. Methods Mol. Biol., 74, 371-377.
32. Nguyen, T.H., Cunningham, L.A., Hammond, K.M. and Lu, Y. (1999) High-resolution preparative-scale purification of RNA using the Prep Cell. Anal. Biochem., 269, 216-218.
33. Lys3 shows a canonical anticodon loop. RNA, 6, 1347-1355.
34. Lys3 expressed in Escherichia coli: identification of posttranscriptional nucleotide modifications required for efficient initiation of HIV-1 reverse transcription. RNA, 6, 1403-1412.
35. Cunningham, L., Kittikamron, K. and Lu, Y. (1996) Preparative-scale purification of RNA using an efficient method which combines gel electrophoresis and column chromatography. Nucleic Acids Res., 24, 3647-3648.
36. Lys3 hybrids. J. Mol. Biol., 261, 315-321.
37. Lys3 binding and the consequences for (-)-strand DNA synthesis. J. Biol. Chem., 273, 14523-14532.
38. Lys3. Nucleic Acids Res., 19, 751-757.
39. Layne, S.P., Merges, M.J., Dembo, M., Spouge, J.L., Conley, S.R., Moore, J.P., Raina, J.L., Renz, H., Gelderblom, H.R. and Nara, P.L. (1992) Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology, 189, 695-714.
40. Lebowitz, J., Kar, S., Braswell, E., McPherson, S. and Richard, D.L. (1994) Human immunodeficiency virus-1 reverse transcriptase heterodimer stability. Protein Sci., 3, 1374-1382.